Fig. 6
From: Factors affecting long-term efficacy of T regulatory cell-based therapy in type 1 diabetes
T1DM autoantibodies in the follow-up. The levels of anti-GAD65, IAA, IA2 and anti-ZnT8 autoantibodies were measured. The values are shown for the untreated controls (NO Tregs), patients treated with single infusion (single dose) and patients treated with two infusions (two doses) during the follow-up. Data are presented as medians (min.–max.), and the open circles represent particular patients